logging in or signing up OBESITY FOR THE STATE Amateur Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 552 Category: News & Reports.. License: All Rights Reserved Like it (0) Dislike it (0) Added: August 09, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript CHILDHOOD OBESITY AN EPIDEMIC: CHILDHOOD OBESITY AN EPIDEMIC INCIDENCE OF CHILDHOOD OBESITY IS INCREASING: INCIDENCE OF CHILDHOOD OBESITY IS INCREASING DEFINING OBESITY IN CHILDREN- THE PEDIATRIC BMI CHART: DEFINING OBESITY IN CHILDREN- THE PEDIATRIC BMI CHART Obese (andgt;95TH %) At Risk ? CAUSATIVE FACTORS-EXCLUDING SYNDROMES: CAUSATIVE FACTORS-EXCLUDING SYNDROMES PRIMARY Poor food choices Inactivity SECONDARY Psychological Environmental Genetics Fetal environment CONSEQUENCES: CONSEQUENCES The epidemic of obesity is affecting children as young as 2 More overweight children are developing, insulin resistance or metabolic syndrome and type 2 diabetes Sleep apnea, asthma, hypertension, orthopedic problems and others If we do not reverse the trend health costs will be astronomical EXCESS SUBSTRATE WITHOUT EXCESS EXPENDITURE=LIPOGENESIS : EXCESS SUBSTRATE WITHOUT EXCESS EXPENDITURE=LIPOGENESIS OBESITY A FATAL DISEASE: OBESITY A FATAL DISEASE TREATMENT OF PEDIATRIC OBESITY: TREATMENT OF PEDIATRIC OBESITY Nutrition management Physical activity Behavior modification / Counselling Family support OUR PRACTICE: OUR PRACTICE Faculty of the UNSOM Full service cardiology program: Echo Cath Surgery Intervention EP Full-time M.D., MPH research director, extensive data base system Pediatric Risk Factor Reduction Program CHILDREN’S HEART CENTER - NEVADA: CHILDREN’S HEART CENTER - NEVADA 15,000 OUT-PATIENT VISITS/YR 6,000 IN-PATIENT VISITS/YR MORE PATIENT VISITS THAN* -UCLA -UCSF -STANFORD -CHILDREN’S HOSPITAL OF LOS ANGELES -LOMA LINDA -CEDARS SINAI *FROM PUBLISHED DATA AND PERSONAL CONVERSATIONS OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM PATIENTS REFERRED BY PRIMARY CARE PROVIDERS Primary care providers without time or staff to treat effectively BMI andgt; 95%ile for age Hypertension with BMI andgt;95%ile Dyslipoproteinemias OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM Initial evaluation Laboratory testing Intensive initial nutritional evaluation andamp; recommendations If appropriate exercise program enrollment If indicated family counselling Follow up LAB TESTS RESULTS IN 410 PATIENTS BMI >95th %tile: LAB TESTS RESULTS IN 410 PATIENTS BMI andgt;95th %tile Average age 11.4 years 44% Females 56% males Average BMI 32.5 Total cholesterol 179 ± 45 HDL 42 ± 10 Triglycerides 149 ± 97 Insulin 22 ± 25 CHILD/ADOLESCENT NORMALS: CHILD/ADOLESCENT NORMALS Total cholesterol andlt; 170 mg/dl HDL andgt; 45 mg/dl- Probably andgt;50 desirable Triglycerides andlt;125- Probably andlt;100 desirable Insulin level andlt;10 (Dr. Sears andlt;5) OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM 12 WEEK INTEGRATED PROGRAM Nutrition counselling Simple psychological evaluation Exercise RX Motivational intervention and family counselling referral if indicated INTAKE DATA FROM OUR PROGRAM: INTAKE DATA FROM OUR PROGRAM 25% Carbs HFCS MOST IMPORTANT NUTRTION-RECOMMENDED INTAKE: MOST IMPORTANT NUTRTION-RECOMMENDED INTAKE WHO WILL WIN THE BATTLE?: WHO WILL WIN THE BATTLE? Soft Drink!? USDA food pyramid BRIEF PSYCHOLOGIC EVALUATION: BRIEF PSYCHOLOGIC EVALUATION Perera self esteem test 16 true or false questions Scored number of 'true answers' Initial and repeated at end of 12 week program EXERCISE : EXERCISE INITIAL EVALUATION Rockport walk test Timed 1 mile walk Score based on time and heart rate Gender and weight Max VO2 estimate andlt;25 Poor, 25-30 Fair, 30-40 Average, 40-50 good, andgt;50 excellent EXERCISE RX: EXERCISE RX AEROBIC Treadmill, bike or walking At home we recommend 30-45 min 3-5x/week Supervised in program 2x per week Our exercise staff tries to achieve 40-70% of VO2 max(estimated) EXERCISE RX: EXERCISE RX ADDITIONAL PROGRAM ACTIVITIES Weights Calisthenics Stretching PROGRAM MATERIALS: PROGRAM MATERIALS Hand outs Homework Off site exercise Behavior modification Positive rewards Slide24: OUR ON SITE EXERCISE FACILITY: OUR ON SITE EXERCISE FACILITY Slide26: INITIAL BIOMETRIC & SELF ESTEEM RESULTS FROM THE 12 WEEK PROGRAM: INITIAL BIOMETRIC andamp; SELF ESTEEM RESULTS FROM THE 12 WEEK PROGRAM RESULTS FROM 12 WEEK PROGRAM: RESULTS FROM 12 WEEK PROGRAM N=76 Average age 12.5 (7-18) Male 56% Female 44% Reported at Society of Pediatric Research in San Francisco May 2004 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 RESTING HR Pre=111 Post=98NS SYSTOLIC BP Pre=123 Post=113* * P andlt;.05 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 BMI Pre=33 Post=32* % BODY FAT Pre=40 Post=38* * P andlt;.05 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 SELF ESTEEM Pre=10.6 Post=12.4* WALK TEST SCORE Pre=10 Post=27* * P andlt;.05 PARENTAL SURVEYED PHYSICAL ACTIVITY AND NUTRITIONAL CHANGES RESULTS FROM 12 WEEK PROGRAM: PARENTAL SURVEYED PHYSICAL ACTIVITY AND NUTRITIONAL CHANGES RESULTS FROM 12 WEEK PROGRAM Slide33: * * * * * P-value andlt; 0.05 TV watching on weekends TV watching on school days Gross Activity Daily Activity Slide34: Breakfast freq. Fruits consump. Vegetables consump. Sodas / Juices * * * * * P-value andlt; 0.05 INSULIN RESISTANCE IN OUR PATIENTS: INSULIN RESISTANCE IN OUR PATIENTS INSULIN RESISTANCE IN OUR PATIENTS: INSULIN RESISTANCE IN OUR PATIENTS Quicki (1/log insulin +log glucose)* Glucose/Insulin ratio** Increasing IR with age and with BMI in euglycemic patients with BMIs andgt;95th%ile. Presented at the AHA LJ Filer San Francisco in March *J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10 ** J Clin Endocrinol Metab. 1998;83:2694-2698 INSULIN RESISTANCE: INSULIN RESISTANCE N=334 *J Clin Endocrinol Metab. 2002 Jan;87(1):144-7. QUICKI VS AGE: QUICKI VS AGE GLUCOSE/INSULIN VS AGE: GLUCOSE/INSULIN VS AGE QUICKI VS BMI: QUICKI VS BMI GLUCOSE/INSULIN VS BMI: GLUCOSE/INSULIN VS BMI CURRENT RESEARCH: CURRENT RESEARCH Analysis of metabolic abnormalities in our population Biometric, psychological and metabolic abnormalities pre and post treatment intervention Effects of Omega 3 fish oil supplementation effect on eicosanoids and inflammation Vascular reactivity Urinary / salivary inflammatory markers CURRENT RESEARCH: CURRENT RESEARCH Maternal factors on fetal environment Infants born SGA/LGA and relationship to obesity in our population Cardiac function/ LV Hypertrophy/ BNP Measured VO2 studies Possible animal studies CURRENT RESEARCH: CURRENT RESEARCH Long term follow up and longitudinal studies Possible pharmacologic intervention ? Cannabinoid receptor inhibitors ? Surgical intervention You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
OBESITY FOR THE STATE Amateur Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 552 Category: News & Reports.. License: All Rights Reserved Like it (0) Dislike it (0) Added: August 09, 2007 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript CHILDHOOD OBESITY AN EPIDEMIC: CHILDHOOD OBESITY AN EPIDEMIC INCIDENCE OF CHILDHOOD OBESITY IS INCREASING: INCIDENCE OF CHILDHOOD OBESITY IS INCREASING DEFINING OBESITY IN CHILDREN- THE PEDIATRIC BMI CHART: DEFINING OBESITY IN CHILDREN- THE PEDIATRIC BMI CHART Obese (andgt;95TH %) At Risk ? CAUSATIVE FACTORS-EXCLUDING SYNDROMES: CAUSATIVE FACTORS-EXCLUDING SYNDROMES PRIMARY Poor food choices Inactivity SECONDARY Psychological Environmental Genetics Fetal environment CONSEQUENCES: CONSEQUENCES The epidemic of obesity is affecting children as young as 2 More overweight children are developing, insulin resistance or metabolic syndrome and type 2 diabetes Sleep apnea, asthma, hypertension, orthopedic problems and others If we do not reverse the trend health costs will be astronomical EXCESS SUBSTRATE WITHOUT EXCESS EXPENDITURE=LIPOGENESIS : EXCESS SUBSTRATE WITHOUT EXCESS EXPENDITURE=LIPOGENESIS OBESITY A FATAL DISEASE: OBESITY A FATAL DISEASE TREATMENT OF PEDIATRIC OBESITY: TREATMENT OF PEDIATRIC OBESITY Nutrition management Physical activity Behavior modification / Counselling Family support OUR PRACTICE: OUR PRACTICE Faculty of the UNSOM Full service cardiology program: Echo Cath Surgery Intervention EP Full-time M.D., MPH research director, extensive data base system Pediatric Risk Factor Reduction Program CHILDREN’S HEART CENTER - NEVADA: CHILDREN’S HEART CENTER - NEVADA 15,000 OUT-PATIENT VISITS/YR 6,000 IN-PATIENT VISITS/YR MORE PATIENT VISITS THAN* -UCLA -UCSF -STANFORD -CHILDREN’S HOSPITAL OF LOS ANGELES -LOMA LINDA -CEDARS SINAI *FROM PUBLISHED DATA AND PERSONAL CONVERSATIONS OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM PATIENTS REFERRED BY PRIMARY CARE PROVIDERS Primary care providers without time or staff to treat effectively BMI andgt; 95%ile for age Hypertension with BMI andgt;95%ile Dyslipoproteinemias OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM Initial evaluation Laboratory testing Intensive initial nutritional evaluation andamp; recommendations If appropriate exercise program enrollment If indicated family counselling Follow up LAB TESTS RESULTS IN 410 PATIENTS BMI >95th %tile: LAB TESTS RESULTS IN 410 PATIENTS BMI andgt;95th %tile Average age 11.4 years 44% Females 56% males Average BMI 32.5 Total cholesterol 179 ± 45 HDL 42 ± 10 Triglycerides 149 ± 97 Insulin 22 ± 25 CHILD/ADOLESCENT NORMALS: CHILD/ADOLESCENT NORMALS Total cholesterol andlt; 170 mg/dl HDL andgt; 45 mg/dl- Probably andgt;50 desirable Triglycerides andlt;125- Probably andlt;100 desirable Insulin level andlt;10 (Dr. Sears andlt;5) OUTLINE OF OUR PROGRAM: OUTLINE OF OUR PROGRAM 12 WEEK INTEGRATED PROGRAM Nutrition counselling Simple psychological evaluation Exercise RX Motivational intervention and family counselling referral if indicated INTAKE DATA FROM OUR PROGRAM: INTAKE DATA FROM OUR PROGRAM 25% Carbs HFCS MOST IMPORTANT NUTRTION-RECOMMENDED INTAKE: MOST IMPORTANT NUTRTION-RECOMMENDED INTAKE WHO WILL WIN THE BATTLE?: WHO WILL WIN THE BATTLE? Soft Drink!? USDA food pyramid BRIEF PSYCHOLOGIC EVALUATION: BRIEF PSYCHOLOGIC EVALUATION Perera self esteem test 16 true or false questions Scored number of 'true answers' Initial and repeated at end of 12 week program EXERCISE : EXERCISE INITIAL EVALUATION Rockport walk test Timed 1 mile walk Score based on time and heart rate Gender and weight Max VO2 estimate andlt;25 Poor, 25-30 Fair, 30-40 Average, 40-50 good, andgt;50 excellent EXERCISE RX: EXERCISE RX AEROBIC Treadmill, bike or walking At home we recommend 30-45 min 3-5x/week Supervised in program 2x per week Our exercise staff tries to achieve 40-70% of VO2 max(estimated) EXERCISE RX: EXERCISE RX ADDITIONAL PROGRAM ACTIVITIES Weights Calisthenics Stretching PROGRAM MATERIALS: PROGRAM MATERIALS Hand outs Homework Off site exercise Behavior modification Positive rewards Slide24: OUR ON SITE EXERCISE FACILITY: OUR ON SITE EXERCISE FACILITY Slide26: INITIAL BIOMETRIC & SELF ESTEEM RESULTS FROM THE 12 WEEK PROGRAM: INITIAL BIOMETRIC andamp; SELF ESTEEM RESULTS FROM THE 12 WEEK PROGRAM RESULTS FROM 12 WEEK PROGRAM: RESULTS FROM 12 WEEK PROGRAM N=76 Average age 12.5 (7-18) Male 56% Female 44% Reported at Society of Pediatric Research in San Francisco May 2004 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 RESTING HR Pre=111 Post=98NS SYSTOLIC BP Pre=123 Post=113* * P andlt;.05 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 BMI Pre=33 Post=32* % BODY FAT Pre=40 Post=38* * P andlt;.05 RESULTS FROM 12 WEEK PROGRAM N=76: RESULTS FROM 12 WEEK PROGRAM N=76 SELF ESTEEM Pre=10.6 Post=12.4* WALK TEST SCORE Pre=10 Post=27* * P andlt;.05 PARENTAL SURVEYED PHYSICAL ACTIVITY AND NUTRITIONAL CHANGES RESULTS FROM 12 WEEK PROGRAM: PARENTAL SURVEYED PHYSICAL ACTIVITY AND NUTRITIONAL CHANGES RESULTS FROM 12 WEEK PROGRAM Slide33: * * * * * P-value andlt; 0.05 TV watching on weekends TV watching on school days Gross Activity Daily Activity Slide34: Breakfast freq. Fruits consump. Vegetables consump. Sodas / Juices * * * * * P-value andlt; 0.05 INSULIN RESISTANCE IN OUR PATIENTS: INSULIN RESISTANCE IN OUR PATIENTS INSULIN RESISTANCE IN OUR PATIENTS: INSULIN RESISTANCE IN OUR PATIENTS Quicki (1/log insulin +log glucose)* Glucose/Insulin ratio** Increasing IR with age and with BMI in euglycemic patients with BMIs andgt;95th%ile. Presented at the AHA LJ Filer San Francisco in March *J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10 ** J Clin Endocrinol Metab. 1998;83:2694-2698 INSULIN RESISTANCE: INSULIN RESISTANCE N=334 *J Clin Endocrinol Metab. 2002 Jan;87(1):144-7. QUICKI VS AGE: QUICKI VS AGE GLUCOSE/INSULIN VS AGE: GLUCOSE/INSULIN VS AGE QUICKI VS BMI: QUICKI VS BMI GLUCOSE/INSULIN VS BMI: GLUCOSE/INSULIN VS BMI CURRENT RESEARCH: CURRENT RESEARCH Analysis of metabolic abnormalities in our population Biometric, psychological and metabolic abnormalities pre and post treatment intervention Effects of Omega 3 fish oil supplementation effect on eicosanoids and inflammation Vascular reactivity Urinary / salivary inflammatory markers CURRENT RESEARCH: CURRENT RESEARCH Maternal factors on fetal environment Infants born SGA/LGA and relationship to obesity in our population Cardiac function/ LV Hypertrophy/ BNP Measured VO2 studies Possible animal studies CURRENT RESEARCH: CURRENT RESEARCH Long term follow up and longitudinal studies Possible pharmacologic intervention ? Cannabinoid receptor inhibitors ? Surgical intervention